Emma Walmsley, GSK CEO

GSK chief Em­ma Walm­s­ley sees pay raise amid 'land­mark' year

GSK chief Em­ma Walm­s­ley saw a slight pay raise amid what she called a “land­mark year” for the com­pa­ny, in­clud­ing the spin­out of its con­sumer health unit Ha­le­on.

The CEO took home rough­ly £8.45 mil­lion in 2022 (near­ly $10.3 mil­lion), up from £8.2 mil­lion the year pri­or. That in­cludes a £37,000 salary boost and an added £868,000 in bonus mon­ey com­pared to 2021, ac­cord­ing to a re­cent re­port.

How­ev­er, her pay pack­age con­tin­ues to lag be­hind oth­er phar­ma chiefs, in­clud­ing fel­low UK-based As­traZeneca CEO Pas­cal So­ri­ot, whose pay pack­age to­taled £15.3 mil­lion (more than $18.6 mil­lion) in 2022. Amer­i­can phar­ma chiefs tend to take home hefti­er pay pack­ages, such as Ab­b­Vie CEO Rick Gon­za­lez, who brought in $26.2 mil­lion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.